Novo Holdings - Latest News and Investment Deals
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Novo Holdings A/S, a private limited liability company fully owned by the Novo Nordisk Foundation, is the holding company in the Novo Group, and responsible for managing the Foundation’s assets. Besides being the major shareholder in the Novo Group companies Novo Nordisk A/S, Novozymes A/S and NNIT A/S, Novo Holdings provides seed and venture capital to development stage companies and takes significant ownership positions in well-established companies within life science, as well as manages a broad portfolio of financial assets. Follow us on Twitter:
TandemAI Closes $22M Series A Extension Round
Salesforce vs Veeva - the Game's Afoot and the Life Sciences Battleground Is Hotting Up!
VC Firm 2150 Raises €210M Fund to Solve Cities’ Climate Challenges
Danish Foodtech REDUCED Brings Series A to €12 Million to Support Industrial Rollout of Clean-Label Savoury Ingredients
Novonesis & DTU to Convert Carbon Into Protein As Part of Bill Gates-Backed Project
Kennedy’s Vaccine Agenda Stalled, Structure’s ‘Competitive’ Obesity Pill, Novo’s Warning Letter
Business Checking Accounts For DTC Founders: Your Operations Command Center
MATR Foods Raises €40M in Series A Equity and Venture Debt
Alveus Therapeutics Secures $37M Series A Extension Funding
Quantonation Ventures Closes €220M Quantum Fund Backed by Toshiba, Novo Holdings and Others
Footprint Fund I Closes €76M Article 9 Deeptech Fund
Expedition Therapeutics Raises $165M Series A Led by Sofinnova Investments and Novo Holdings
Hemab Therapeutics Raises $157M in Series C Led by Sofinnova Partners
